Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3 label.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:25:01.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:30:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:54:14.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include a glossary toggle, label capitalization tweaks (Last Update Submitted that Met QC Criteria and No FEAR Act data), and a new revision indicator (v3.4.0), which do not alter study data or core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:29:10.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.3 to v3.3.4. There are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:44.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.